Send feedback

DDHD2 p.Ser472Ile

c.1415G>T · rs770759164 · VCV2198563

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.0808 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00169%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
hereditary spastic paraplegia 54

Computational evidence

Protein change
AlphaMissense0.0808likely benign
REVEL0.042moderately benign-leaning
SaProtLLR -7.72tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.4GERP -1.9
Regional constrainto/e 0.91unconstrained · MANE · 21 kb · p 0.01 · regional, not allelic
Overall
CADD4.134PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00169% European (non-Finnish) · 20/1,180,040 alleles
Filtering AF 0.00111% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0009%
Overall 0.00142% 23/1,614,088 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0048% 20,828
European (non-Finnish)grpmax 0.00169% 59,002

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DDHD2
Protein
p.Ser472Ile
Coding
c.1415G>T
MANE Select
NM_015214
dbSNP
rs770759164
Type
single nucleotide variant
Location
chr8:38251982 (GRCh38)
Gene constraint
LOEUF 0.758 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 74.70
Residue 472
a UniProt-annotated variant site (in spg54; likely pathogenic; loss of triacylglycerol hydrolase activity)
Full DDHD2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 54 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Autosomal recessive spastic paraplegia type 54 (Orphanet):

Inheritance
Autosomal recessive
Onset
Childhood, Infancy

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ddhd2-p-ser472ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown